Skip to main content
. 2019 Dec 17;11:1759720X19895492. doi: 10.1177/1759720X19895492

Figure 6.

Figure 6.

Odds ratio of major adverse cardiovascular events in patients with IMIDs treated with 10 mg tofacitinib twice daily as compared with 5 mg.